ClinConnect ClinConnect Logo
Search / Trial NCT05623566

Evaluation of a Smartphone Based Screening Tool for Neonatal Jaundice in Surabaya, Indonesia

Launched by PICTERUS AS · Nov 18, 2022

Trial Information

Current as of July 23, 2025

Terminated

Keywords

ClinConnect Summary

A cross-sectional conductive study aiming to evaluate the accuracy of a novel smartphone application that estimates bilirubin levels in newborns at Airlangga University hospital and RSIA Kendangsari MERR in Surabaya.

This cross-sectional study evaluates the accuracy of a novel smartphone application that estimates bilirubin levels in Indonesian newborns. The Picterus Calibration Card was placed on the chest of the newborn with the hole in the card placed over the infant's sternum. A validated smartphone with Picterus JP was used to collect digital images.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Infants born with gestational age \>31
  • Birth weight ≥ 1500g
  • Age 0 - ≤14 days
  • Consent obtained from the parents
  • Exclusion Criteria:
  • Infants born with congenital abnormalities;
  • Infants respiratory support;
  • Infants suffering from a condition that may alter the skin tissue circulatory system, such as sepsis and heart failure;
  • Infants who have received phototherapy in the last 24 hours.

About Picterus As

Picterus AS is an innovative clinical trial sponsor dedicated to advancing medical research through the development of cutting-edge imaging technologies. Specializing in the integration of artificial intelligence and machine learning with diagnostic imaging, Picterus AS aims to enhance the accuracy and efficiency of clinical trials. By leveraging state-of-the-art methodologies and a commitment to patient-centered outcomes, the company seeks to optimize the drug development process and improve therapeutic interventions across various healthcare sectors. With a focus on collaboration and scientific rigor, Picterus AS is positioned to make significant contributions to the future of medical diagnostics and treatment efficacy.

Locations

Surabaya, East Java, Indonesia

Surabaya, East Java, Indonesia

Surabaya, East Java, Indonesia

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials